Product Information
TICAGRELOR 60 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.2821 per EA under NDC 76282058460. Its NADAC has been published 36 times since Jan 28, 2026.
FDA first approved this application on May 5, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Exelan Pharmaceuticals Inc.NDC
76282058460
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
TICAGRELORApproval Type
Generic (ANDA)
FDA Application
ANDA208537FDA Approved
5/5/2025
TE Code
AB
On Market Since
10/29/2025
Pharmacological Classes
Price Statistics
The NADAC for TICAGRELOR 60 MG TABLET has been published 36 times since Jan 28, 2026, and over the history we have for it it has declined 93.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2821 per EA |
|---|---|
| All-time high | $4.1321 (Feb 11, 2026) |
| All-time low | $0.2821 (Sep 23, 2026) |
| 52-week high | $4.1321 |
| 52-week low | $0.2821 |
| Median price | $0.3197 |
| Average price | $0.9018 |
| Largest weekly change | -73.8% (Mar 18, 2026) |
| Weeks tracked | 36 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Exelan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TICAGRELOR market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
P2Y12 Platelet Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TICAGRELOR 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TICAGRELOR 60 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.2821 per EA (NDC 76282058460), effective Sep 30, 2026.
How has the price of TICAGRELOR 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for TICAGRELOR 60 MG TABLET has declined 93.2%. It has been tracked across 36 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for TICAGRELOR 60 MG TABLET?
Since Jan 28, 2026, the NADAC for TICAGRELOR 60 MG TABLET has ranged from a low of $0.2821 (Sep 23, 2026) to a high of $4.1321 (Feb 11, 2026), with a median of $0.3197 per EA.
Are there cheaper alternatives to TICAGRELOR 60 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TICAGRELOR 60 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TICAGRELOR 60 MG TABLET?
TICAGRELOR 60 MG TABLET (NDC 76282058460) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.